ClosedRegulation
Ophthalmic and Topical Dosage Form New Animal Drugs; Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension
Health and Human Services Department, Food and Drug Administration
Closed
NAICS 325412
Source: Federal Register
OverviewIntelligenceProposals
Key Details
- Posted Date
- Response Deadline
- NAICS Code
- 325412
- Source
- Federal Register
- Contract Type
- regulation
Description
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Virbac AH, Inc. The NADA provides for the veterinary prescription use of a hydrocortisone aceponate, miconazole nitrate, and gentamicin sulfate suspension for the treatment of otitis externa in dogs.
Key Dates
Posted:→Deadline:
Frequently Asked Questions
Is this regulation still open?+
No — the response deadline for this regulation has passed (December 16, 2011). Browse other active Health and Human Services Department, Food and Drug Administration opportunities on Bureauify.
How do I apply for this regulation?+
Review the full solicitation documents on the source website (SAM.gov or Grants.gov), prepare your proposal per the instructions, and submit before the deadline. Use Bureauify to track the opportunity and get reminders.
Track This Regulation
Get alerts and track updates with Bureauify.
Track in BureauifyView on Federal RegisterIntelligence
- Win probability analysis
- Competitive landscape
- Incumbent analysis
- Price-to-win estimate
- Similar awards history
Data sourced from Federal Register